Hepatocellular carcinoma-targeted nanoparticles for cancer therapy.

about

Hepatocellular carcinoma-targeted nanoparticles for cancer therapy.

Item

http://www.wikidata.org/entity/Q47097723

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Hepatocellular carcinoma-targeted nanoparticles for cancer therapy.

@en

Hepatocellular carcinoma-targeted nanoparticles for cancer therapy.

@nl

type

Item

label

Hepatocellular carcinoma-targeted nanoparticles for cancer therapy.

@en

Hepatocellular carcinoma-targeted nanoparticles for cancer therapy.

@nl

prefLabel

Hepatocellular carcinoma-targeted nanoparticles for cancer therapy.

@en

Hepatocellular carcinoma-targeted nanoparticles for cancer therapy.

@nl

P1476

Hepatocellular carcinoma-targeted nanoparticles for cancer therapy

@en

P2093

Chien-Hsun Wu

http://www.w3.org/2001/XMLSchema#string

Chun-Hsin Lan

http://www.w3.org/2001/XMLSchema#string

Han-Chung Wu

http://www.w3.org/2001/XMLSchema#string

Kuan-Lin Wu

http://www.w3.org/2001/XMLSchema#string

Wann-Neng Jane

http://www.w3.org/2001/XMLSchema#string

Yao-Ming Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

A novel peptide specifically binding to nasopharyngeal carcinoma for targeted drug delivery.

Direct fluorochrome labeling of phage display library clones for studying binding specificities: applications in flow cytometry and fluorescence microscopy.

Peptidic tumor targeting agents: the road from phage display peptide selections to clinical applications.

Single chain anti-c-Met antibody conjugated nanoparticles for in vivo tumor-targeted imaging and drug delivery.

In vivo targeting of B-cell lymphoma with glycan ligands of CD22.

The FDA critical path initiative and its influence on new drug development.

Influence of affinity and antigen internalization on the uptake and penetration of Anti-HER2 antibodies in solid tumors

Hepatocellular carcinoma: clinical frontiers and perspectives.

Cell-specific delivery of diverse cargos by bacteriophage MS2 virus-like particles

P304

389-401

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/IJO.2017.4205

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael Hsiao

P577

2017-11-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29207071

http://www.w3.org/2001/XMLSchema#string

P932

5741373

http://www.w3.org/2001/XMLSchema#string